Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 2 Heart Diseases 1 Cardiotoxicity 1

Interventions

Antineoplastic Agents 3 Echocardiography 2 Blood Specimen Collection 2 Vital Signs 1 Surveys and Questionnaires 1 Specimen Handling 1 Mass Screening 1 Interviews as Topic 1 Immunomodulating Agents 1 Immune Checkpoint Inhibitors 1 Hematologic Tests 1 Exercise Test 1 Diagnosis 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Heart Diseases × Immunomodulating Agents × Clear all

NCT03530215 2023-04-13

EROCA

Groupe Hospitalier Pitie-Salpetriere

500,000 enrolled

Heart Diseases, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡